ArticleMicroorganisms2025

Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in Poland.

Andrzej Załęski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.